Is Dextran 70 registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Dextran 70.

Is Dextran 70 on the WHO Model List of Essential Medicines?

Yes — 11.4. Plasma substitutes (core list): Hypovolaemia.

Active substance

Dextran 70

SFDA 2
WHO EML 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
DEXTRAN 70 6% IN DEXTROSE	6 %	Solution for infusion · Intravenous use	1 Bottle	SAR 45.95	NCE · Prescription	B. BRAUN	Withdrawn by MAH · Not Marketed
DEXTRAN 70 6% IN NORMAL SALINE	6, 0.9 %	Solution for infusion · Intravenous use	1 Bottle	SAR 45.95	NCE · Prescription	B. BRAUN	Withdrawn by MAH · Not Marketed

WHO WHO Model List of Essential Medicines (2025)

11.4. Plasma substitutes · core
Hypovolaemia
Parenteral > General injections > IV: 6% injectable solution

Combinations containing Dextran 70

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.